Drug intelligence / Profile preview

fospropofol + fentanyl

Development stage
Unknown
Lead developer
Eisai
Modality
Small Molecules
Administration
Intravenous
01

Overview

**Fospropofol + fentanyl** is a pharmaceutical combination used for the induction and maintenance of procedural sedation and anesthesia in medical settings, particularly during minor surgical procedures and diagnostic interventions. **Fospropofol** is a water-soluble prodrug of propofol, metabolized in the body to release active propofol, providing sedative and hypnotic effects. **Fentanyl** is a potent synthetic opioid analgesic that acts on μ-opioid receptors, providing rapid and profound analgesia and contributing to sedation. The combination is typically administered intravenously, with fentanyl given prior to fospropofol to enhance analgesia and facilitate a smoother induction of sedation or anesthesia. This regimen has demonstrated efficacy in achieving deep sedation with rapid recovery and high patient and clinician satisfaction. It is commonly used in procedures such as endoscopy and bronchoscopy, and especially in settings where pain and discomfort must be minimized with rapid post-procedure recovery[4][5][7].

Other names
fospropofol and fentanyl
02

Targets

GABRR (GABA-A receptor subunit rho)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on fospropofol + fentanyl.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fospropofol + fentanyl.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call